Algernon Pharmaceuticals Inc. C.AGN

Alternate Symbol(s): AGNPF

Algernon Pharmaceuticals Inc. is a clinical-stage drug development company. The Company is focused on developing repurposed therapeutic drugs in the areas of non-alcoholic steatohepatitis (NASH), a type of liver disease, chronic kidney disease (CKD), inflammatory bowel disease (IBD), idiopathic pulmonary fibrosis (IPF) and chronic cough as well as advancing a stroke program using N, N-Dimethyltryptamine (DMT). The Company operates through two segments, which includes the development of repurposed therapeutic drugs in Canada and the facilitation of the Company’s lead drug candidates into off-label phase II clinical trials (humans) in Australia. The Company's pipeline includes NP-251 (Repirinast) and AP-188 (DMT). The Company, through its subsidiary, Algernon NeuroScience Inc., is developing AP-188 (DMT) as a potential treatment for stroke and traumatic brain injury (TBI) recovery. Its NP-251 is being developed as a potential treatment for kidney inflammation and fibrosis.

CSE:AGN - Post by User

Algernon Pharmaceuticals Inc.

Bullboard Posts

Comment by grosdavidon Apr 14, 2020 11:41am

75 Views

Post# 30907549

RE:RSI is 74 way over bought

Don't know what you are trying to analyze here little man, how can you use RSI on a stock that just soared more than 50% yesterday on a NR stating FDA is backing the initial findings of AGN.

I don't think you understand what technicals are for a penny stock and I don't know what you are trying to conclude with your 200 day moving average. I just think if you put the actual situation into perspective, nothing make sense with your previous post. Like no sh!t the RSI indicates that...

Bullboard Posts

Advancing flagship Ishkõday Gold Project in Ontario